Molecular diagnostics: an FDA perspective.

Abstract excerpt

The potential medical applications of microarrays and in vitro diagnostic devices for global assessments of DNA sequence variations, relative RNA abundance and measurements of proteins have generated much excitement, and some skepticism, within the biomedical community. It has been suggested that within the next decade these microarrays and diagnostic devices will be routinely used in the selection, assessment...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Drug Industry
• Share to Government Regulation
• Share to Molecular Diagnostic Techniques